![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.16, Iss.2, 2006-03, pp. : 253-264
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thalidomide improves response rate, survival in multiple myeloma
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Modeling red blood cell survival data
By Korell Julia
Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 6, 2011-12 ,pp. :